The current price of GYRE is $4.01 — it has decreased by 9.68% since the previous close. Data as of Nov 5, 2026.
GYRE is down 36.04% over the past week, down 45.44% over the past month and down 45.74% over the past year. The price is below its 200-day moving average of $6.94.
Of the 3 analysts covering Gyre Therapeutics, Inc., 3 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Gyre Therapeutics, Inc. has a market capitalization of $425.2M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Gyre Therapeutics, Inc. posted earnings of $0.04 per share against an estimate of -$0.15, beating expectations by 126.67%. Upcoming reports are listed in the earnings calendar.
Gyre Therapeutics, Inc. reported revenue of $32.93M in its most recent quarter, which has increased by 7.75% compared with the same quarter a year earlier. Analysts had expected $28.4M.
Gyre Therapeutics, Inc. has not paid any dividends over the past year.
In the latest trading session GYRE moved between $4.00 and $4.50, a range of 12.47% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Gyre Therapeutics, Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GYRE has traded between $3.97 and $9.14. The current price is 56.13% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.